Predictors of low cardiac output in decompensated severe heart failure

Clinics

Volumn 66, Issue 2, 2011, Pages 239-244

  Ochiai, Marcelo Eidi ^a   Cardoso, Juliano Novaes ^a   Vieira, Kelly Regina Novaes ^a   Lima, Marcelo Villaça ^a   Brancalhao, Euler Cristovan Ochiai ^a   Barretto, Antonio Carlos Pereira ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Aged; Chagas disease; Decompensation; Prognosis

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ARTICLE; BLOOD; CHAGAS DISEASE; EPIDEMIOLOGY; FEMALE; FORWARD HEART FAILURE; HEART FAILURE; HEART STROKE VOLUME; HUMAN; HYPONATREMIA; KIDNEY DISEASE; MALE; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PHYSIOLOGY; REFERENCE VALUE; RISK FACTOR;

CARDIAC OUTPUT, LOW; CHAGAS DISEASE; EPIDEMIOLOGIC METHODS; FEMALE; HEART FAILURE; HUMANS; HYPONATREMIA; KIDNEY DISEASES; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; REFERENCE VALUES; RISK FACTORS; STROKE VOLUME;

EID: 79955501425     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322011000200010     Document Type: Article

References (20)

1. Gheorghiade M, Abraham WT, Albert NM, Gattis Stough W, Greenberg BH, O'Connor CM, et al. OPTIMIZE-HF Investigators and Coordinators. Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry. Eur Heart J. 2007;28:980-988, doi: 10.1093/eurheartj/ehl542.
2. Abraham WT, Adams KF, Fonarow GC, Costanzo MR, Berkowitz RL, LeJemtel TH, et al. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). J Am Coll Cardiol. 2005;46:57-64, doi: 10.1016/j.jacc.2005.03.051.
3. Nohria A, Tsang SW, Fang JC, Lewis EF, Jarcho JA, Mudge GH, et al. Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure. J Am Coll Cardiol. 2003;41:1797-1804, doi: 10.1016/S0735-1097(03)00309-7.
4. Bern C, Montgomery SP, Herwaldt BL, Rassi Jr. A, Marin-Neto JA, Dantas RO, et al. Evaluation and treatment of Chagas Disease in the United States. A systematic review. JAMA. 2007;298:2171-2181, doi: 10.1001/jama.298.18.2171.
5. Hauptman PJ, Goodlin SJ, Lopatin M, Costanzo MR, Fonarow GC, Yancy C. Characteristics of patients hospitalized with acute decompensated heart failure who are referred for hospice care. Arch Intern Med. 2007;167:1990-1997, doi: 10.1001/archinte.167.18.1990.
6. Nohria A, Lewis E, Stevenson LW. Medical management of advanced heart failure. JAMA. 2002;287:628-640, doi: 10.1001/jama.287.5.628
7. O'Meara E, Chong KS, Gardner RS, Jardine AG, Neilly JB, McDonagh TA. The Modification of Diet in Renal Disease (MDRD) equations provide valid estimations of glomerular filtration rates in patients with advanced heart failure. Eur J Heart Fail. 2006;8:63-67, doi: 10.1016/j. ejheart.2005.04.013.
8. Hosmer DW, Lemeshow S. Applied logistic regression. New York: Wiley; 1989. p. 106-118.
9. Lee ET. Statistical methods for survival data analysis. 1st ed. Belmont (CA): Lifetime Learning Publications; 1980.
10. Tostes S Jr, Bertulucci Rocha-Rodrigues D, de Araujo Pereira G, Rodrigues V Jr. Myocardiocyte apoptosis in heart failure in chronic Chagas' disease. Int J Cardiol. 2005;18:233-237, doi: 10.1016/j.ijcard.2004.01.026.
11. Rassi A Jr, Rassi A, Little WC, Xavier SS, Rassi SG, Rassi AG, et al. Development and validation of a risk score for predicting death in Chagas' heart disease. N Engl J Med. 2006;355:799-808, doi: 10.1056/NEJMoa053241.
12. Negrão CE, Santos AC, Rondon MU, Franco FG, Ianni B, Rochitte CE, et al. Muscle sympathetic nerve activity in patients with Chagas' disease. Int J Cardiol. 2009;137:252-259, doi: 10.1016/j.ijcard.2008.06.093.
13. Guimaraes GV, D'Avila V, Bocchi EA, Carvalho VO. Norepinephrine remains increased in the six-minute walking test after heart transplantation. Clinics. 2010;65:587-91.
14. Vilas-Boas F, Feitosa GS, Soares MB, Pinho-Filho JA, Nascimento T, Barojas MM, et al. Invasive and noninvasive correlations of B-type natriuretic Peptide in patients with heart failure due to chagas cardiomyopathy. Congest Heart Fail. 2008;14:121-126, doi: 10.1111/j.1751-7133. 2008.08166.x.
15. Krumholz HM, Chen YT, Vaccarino V, Wang Y, Radford MJ, Bradford WD, et al. Correlates and impact on outcomes of worsening renal function in patients.65 years of age with heart failure. Am J Cardiol. 2000;85:1110-1113, doi: 10.1016/S0002-9149(00)00705-0.
16. Ochiai ME, Franco LL, Gebara OC, Nussbacher A, Serro-Azul JB, Pierri H, et al. [Correlation between evolution of the cognitive function and mortality after hospital discharge in elderly patients with advanced heart failure]. Arq Bras Cardiol. 2004;82:251-254, doi: 10.1590/S0066-782X2004000300005.
17. Tang WH, Mullens W. Cardiorenal syndrome in decompensated heart failure. Heart. 2010;96:255-260, doi: 10.1136/hrt.2009.166256.
18. Aronson D, Burger AJ. The relationship between transient and persistent worsening renal function and mortality in patients with acute decompensated heart failure. J Card Fail. 2010;16:541-547, doi: 10.1016/j.cardfail. 2010.02.001.
19. Amsalem Y, Garty M, Schwartz R, Sandach A, Behar S, Caspi A, et al. Prevalence and significance of unrecognized renal insufficiency in patients with heart failure. Eur Heart J. 2008;29:1029-1036, doi: 10.1093/eurheartj/ehn102.
20. O'Meara E, Chong KS, Gardner RS, Jardine AG, Neilly JB, McDonagh TA. The Modification of Diet in Renal Disease (MDRD) equations provide valid estimations of glomerular filtration rates in patients with advanced heart failure. Eur J Heart Fail. 2006;8:63-67, doi: 10.1016/j.ejheart.2005.04.013.